BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
1.040
-0.020 (-1.89%)
Apr 29, 2026, 12:06 PM EDT - Market open
BioXcel Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 28.42 | 29.85 | 65.22 | 193.73 | 232.97 | Upgrade
|
| Cash & Short-Term Investments | 28.42 | 29.85 | 65.22 | 193.73 | 232.97 | Upgrade
|
| Cash Growth | -4.82% | -54.23% | -66.33% | -16.84% | 9.31% | Upgrade
|
| Accounts Receivable | 0.23 | 0.13 | 0.07 | 0.25 | - | Upgrade
|
| Receivables | 0.23 | 0.13 | 0.07 | 0.25 | - | Upgrade
|
| Inventory | 0.72 | 0.68 | 1.99 | 1.99 | - | Upgrade
|
| Prepaid Expenses | 4.03 | 5.29 | 2.78 | 3.07 | 2.89 | Upgrade
|
| Restricted Cash | 0.34 | - | - | - | - | Upgrade
|
| Other Current Assets | 10.95 | 1.44 | 2.08 | 3.84 | 0.96 | Upgrade
|
| Total Current Assets | 44.69 | 37.39 | 72.14 | 202.87 | 236.81 | Upgrade
|
| Property, Plant & Equipment | 0.23 | 0.86 | 1.47 | 2.06 | 2.54 | Upgrade
|
| Other Long-Term Assets | - | 0.09 | 0.09 | 0.93 | 0.09 | Upgrade
|
| Total Assets | 44.92 | 38.34 | 73.7 | 205.85 | 239.44 | Upgrade
|
| Accounts Payable | 14.7 | 15.99 | 13.65 | 10.23 | 4.68 | Upgrade
|
| Accrued Expenses | 4.45 | 5.78 | 13.15 | 22.18 | 11.39 | Upgrade
|
| Current Portion of Long-Term Debt | 24.93 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 0.07 | - | - | - | - | Upgrade
|
| Current Income Taxes Payable | 0.03 | 0.09 | 0.12 | 0.08 | 0.3 | Upgrade
|
| Other Current Liabilities | 9.75 | 0.37 | 0.35 | 0.4 | 0.29 | Upgrade
|
| Total Current Liabilities | 53.93 | 22.23 | 27.27 | 32.9 | 16.67 | Upgrade
|
| Long-Term Debt | 84.66 | 102.51 | 100.6 | 93.05 | - | Upgrade
|
| Long-Term Leases | - | 0.07 | 0.44 | 0.79 | 1.11 | Upgrade
|
| Other Long-Term Liabilities | 1.79 | 6.63 | 1.91 | 2.34 | - | Upgrade
|
| Total Liabilities | 140.38 | 131.44 | 130.21 | 129.08 | 17.77 | Upgrade
|
| Common Stock | 0.08 | 0.05 | 0.03 | 0.03 | 0.03 | Upgrade
|
| Additional Paid-In Capital | 624.56 | 557.05 | 534.06 | 488.29 | 467.43 | Upgrade
|
| Retained Earnings | -720.09 | -650.2 | -590.6 | -411.55 | -245.79 | Upgrade
|
| Shareholders' Equity | -95.46 | -93.1 | -56.51 | 76.78 | 221.67 | Upgrade
|
| Total Liabilities & Equity | 44.92 | 38.34 | 73.7 | 205.85 | 239.44 | Upgrade
|
| Total Debt | 109.66 | 102.57 | 101.04 | 93.84 | 1.11 | Upgrade
|
| Net Cash (Debt) | -81.24 | -72.72 | -35.82 | 99.89 | 231.86 | Upgrade
|
| Net Cash Growth | - | - | - | -56.92% | 9.51% | Upgrade
|
| Net Cash Per Share | -6.65 | -28.69 | -19.67 | 57.05 | 140.67 | Upgrade
|
| Filing Date Shares Outstanding | 27.07 | 5.49 | 1.91 | 1.81 | 1.75 | Upgrade
|
| Total Common Shares Outstanding | 22.33 | 3.1 | 1.87 | 1.76 | 1.75 | Upgrade
|
| Working Capital | -9.24 | 15.16 | 44.88 | 169.97 | 220.15 | Upgrade
|
| Book Value Per Share | -4.28 | -30.01 | -30.21 | 43.64 | 126.76 | Upgrade
|
| Tangible Book Value | -95.46 | -93.1 | -56.51 | 76.78 | 221.67 | Upgrade
|
| Tangible Book Value Per Share | -4.28 | -30.01 | -30.21 | 43.64 | 126.76 | Upgrade
|
| Machinery | 0.78 | 0.78 | 0.78 | 0.79 | 0.74 | Upgrade
|
| Construction In Progress | - | - | - | - | 0.02 | Upgrade
|
| Leasehold Improvements | 1.2 | 1.2 | 1.2 | 1.18 | 1.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.